NOV
03

Updated CLEAR-III Bedside Worksheets

The Bedside Worksheets for collecting data in the CLEAR-III trial were recently updated to better match the EDC screens as well as correct a few errors. Please download (see below) this new version and discard any older versions. Here's a summary of the changes.

Continue reading
OCT
26

CLEAR-III Tips from a UCLA Coordinator

On the ICP Management form, there's a requirement to record the highest and lowest blood pressure within a 4-hour period. The determination of what is the highest and what is the lowest pressure in that period is based on mean arterial pressure (MAP). At UCLA, our system calculates MAP with an algorithm that doesn't completly agree with the equation MAP=((2xDBP)+SBP)/3, so I created an Excel spreadsheet to help identify the highest/lowest pressure.

Continue reading
JAN
25

CLEAR-III Screen Failure Classification Change

screen failure classification question on CLEAR-III EDC demographics form

An interesting early observation from the study has been the seemingly high frequency of Moyamoya disease in the population of potential candidates for this trial. The term Moyamoya is derived from the Japanese word for “puff of smoke” which is how the small weak vessels that develop to compensate for the constriction caused by this disease appear on angiography.

Continue reading
Tags:
EDC
JAN
15

New CLEAR-III Outcomes Tracking Report

Outcomes summary report from the CLEAR-III EDC.The Coordinating Center (but not the monitoring team) is blinded to the outcomes data from Day 30 to Day 365, so tracking what data we have and what we don’t has been a challenge. To our rescue comes a new summary report that can now be accessed by clicking the SUMMARY button while viewing a list of patients or a list of sites. The green checks indicate the outcome questionnaire has been completed. The red “x’s” indicate an assessment that might be missing.

Continue reading
Tags:
EDC

MISTIE-3 Site Locations